Switzerland· 67941012

Buvidal Depot

A buprenorphine product containing buprenorphinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC N07BC01

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedBuvidal DepotATCN07BC01REGISTER NO.67941012PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Buprenorphine is registered in 13 of 19 countries.

Countries holding a registration under ATC N07BC01 (buprenorphine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Buprenorphine · ATC N07BC01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buprenorphine costs, country by country.

Normalised to the WHO defined daily dose (1.6 mg), the median price runs from $1.13 in Switzerland to $4.31 in Spain — a ×3.8 gap.

  • Switzerland: $1.13 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Buprenorphine · price per daily dose (1.6 mg)

USD · FX 28 Sept 2026

  • ES Spain$4.31
  • IT Italy$3.30
  • CH Switzerland$1.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
buprenorphinum
Manufacturer
—
Country
Switzerland (CH)
ATC code
N07BC01
ATC class
Buprenorphine
Defined daily dose
1.6 mg, Implantat
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680679410121
    Fertspr 1 Stk
    CHF 273.75

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

376 interactions on record for buprenorphine.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Buprenorphine · interactions on record

376 records

  • 59 severe
  • 253 moderate
  • 2 minor
  • 52 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • DronabinolA04AD10severe

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buprenorphine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buprenorphine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Astec, Bupensan
  • Belgium · Temgesic, Transtec
  • Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
  • Cyprus · Buvera
  • Czechia · Addnok, Buprenorfin Stada
  • Germany · Acimaphin, Acinorphin
  • Denmark · Buprefarm, Bupremyl
  • Estonia · Buprenorphine G.L. Pharma
  • Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
  • Finland · Buprefarm, Bupremyl
  • France · Bupensan, Buprenorphine Arrow
  • United Kingdom (Northern Ireland) · Addnok, Bunov
  • Greece · Buprenal, Buvera
  • Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
  • Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
  • Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
  • Italy · Buprenorfina Molteni, Buprenorfina Sandoz
  • Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
  • Luxembourg · Temgesic, Temgesic Sublingualis
  • Latvia · Buprenorphine G.L. Pharma
  • Malta · Buprenorphine Aspire Pharma (Malta), Natzon
  • Netherlands · Buprenorfine, Buprenorfine 1a Pharma
  • Norway · Bugnanto, Buprefarm
  • Poland · Bunondol, Bunorfin
  • Portugal · Buprenorfina, Buprenorfina Aurovitas
  • Sweden · Buprefarm, Buprenorfin Actavis
  • Slovenia · Addnok, Buprenorfin Alkaloid-Int
  • Slovakia · Bupretec, Noprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9e371b3-3113-4e52-a560-6d8e44bf9754
GET /v1/drugs/d9e371b3-3113-4e52-a560-6d8e44bf9754?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "buprenorphinum 64 mg",
  "valid_from": "2025-01-01",
  "limitations": "[{\"description\":\"Gemäss Anhang 1 zur KLV (SR 832.112.31), vgl. Kapitel 8, Psychiatrie und Psychotherapie, Opioidagonistentherapie (OAT) bei Opioidabhängigkeitssyndrom.<br>\\n<br>\\nZur Substitutionsbehandlung bei Opioidabhängigkeit, bei Patienten, bei denen eine orale Buprenorpintherapie ungenügend angesprochen hat.<br>\\nDie Wochen-Depot-Injektion dient zur Anbehandlung.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-01-01\",\"validTo\":null}]",
  "galenic_form": "Inj Lös 64 mg/0.18ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2025-01-01",
  "self_retention_pct": 10
}

See everything about buprenorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.